Koffset-LS Syrup Sugar Free is a combination pharmaceutical formulation containing Levosalbutamol (1mg/5ml), Ambroxol (30mg/5ml), and Guaifenesin (50mg/5ml), designed for the management of respiratory conditions characterized by bronchospasm and excessive mucus production. Levosalbutamol, a selective β2-adrenergic receptor agonist, acts as a bronchodilator by relaxing the smooth muscles of the airways, thereby improving airflow and alleviating symptoms of bronchoconstriction such as wheezing and shortness of breath. Ambroxol serves as a mucolytic agent, facilitating the breakdown and clearance of viscous mucus in the respiratory tract, enhancing expectoration and reducing cough frequency. Guaifenesin acts as an expectorant, promoting the hydration of respiratory secretions and aiding in the removal of mucus from the airways. The sugar-free formulation makes Koffset-LS Syrup suitable for patients with diabetes or those requiring sugar-restricted diets. This combination therapy is indicated for the symptomatic relief of conditions such as bronchitis, asthma, chronic obstructive pulmonary disease (COPD), and other respiratory tract infections where bronchospasm and mucus hypersecretion coexist. Administration should follow medical advice, considering contraindications and potential drug interactions. Common adverse effects may include tremors, headache, or gastrointestinal discomfort, warranting monitoring during therapy.